Your Article Summary
Clinical Development in the Nordic Region & Northern Europe
PharmiWeb, 12/01/08
The Nordic and Northern European region is widely regarded as a very attractive location to run clinical studies. However, like other western European countries, clinical site saturation is becoming an important issue in this region as the number of studies increase, as well as their complexity. Nordic and Northern European countries must maintain their competitive edge in contrast to other emerging clinical regions with larger, treatment naive patient populations.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
PR distribution service for the biotech industry
b3c newswire, 12/07/09
Safety First in Biotech Development
BioPharm, 12/03/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Cerner Enters R&D Pact with University
HealthDataManagement, 12/08/09
Report: Acquisition Activity Down
HealthDataManagement, 12/08/09
Takeda to Continue Strategic Expansion with Operations in Brazil
Takeda Pharmaceuticals North America, 12/08/09
Article Search
Sponsor


See Latest Articles


